Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib was effective in treating hair loss in adults with alopecia areata according to patient feedback.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Psoriasis patients on biologic therapy have a weaker immune response to COVID-19 vaccination than healthy people.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

PRPF is a safer and more effective treatment for hair loss than PRP.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

Two new IRAK4-inhibitors effectively reduced skin inflammation and immune response markers in healthy volunteers.

Baricitinib was effective in treating both early and late onset alopecia areata.

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

Blocking certain proteins can significantly regrow hair in severe alopecia areata.

Atopy and altered T cell functions contribute to Alopecia Areata.

Enhancing Tregs can protect against alopecia areata.

Retinoids may help treat lupus nephritis and reduce steroid use.

JAK inhibitors can help regrow hair in alopecia areata but have potential long-term risks and require careful monitoring.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

The combination of PRP and triamcinolone injections improved hair growth in a man with alopecia areata.

Baricitinib is more effective than methotrexate for severe alopecia areata.

Finasteride helps improve treatment for benign prostatic hyperplasia.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

A woman with severe hair loss saw significant hair regrowth after adding platelet-rich plasma injections to her treatment with tofacitinib.

FGF-2&D/P nanoparticles can help treat hair loss.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.